New findings presented at the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto spotlighted the long-term potential of two FDA-approved Alzheimer’s treatments for people with ...

Subtyping is what made precision medicine in cancer a reality. And for successful drug discovery in all its stages, finding ...

At just 29 years old, the Queensland mum has been diagnosed with a rare hereditary form of Alzheimer’s disease. It is the ...

Early dementia signs can resemble the normal cognitive changes of aging. But timely diagnosis can help people get the ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...